The pandemic continues to cause unprecedented disruption across industries worldwide.
Get detailed insights regarding the impact of COVID-19 on the market.
The global neuroscience market was valued at US$ 32.22 Billion in 2021.
We expect the global neuroscience market to exhibit a CAGR of 3.80% during 2022-2027.
The high prevalence of numerous neurological disorders, such as Alzheimer's, schizophrenia, brain stroke, etc., is primarily driving the global neuroscience market.
The sudden outbreak of the COVID-19 pandemic has led to the extensive R&D activities in the field of neuroscience for providing insights into neurological and psychological functioning, that is adversely impacted by the coronavirus disease.
Based on the component, the global neuroscience market has been divided into instruments and consumables and software and services. Currently, instruments and consumables exhibit a clear dominance in the market.
Based on the technology, the global neuroscience market can be segmented into brain imaging, neuro-microscopy, electrophysiology, neuroproteomic analysis, animal behaviour analysis, and others. Among these, brain imaging holds the majority of the total market share.
On a regional level, the market has been classified into North America, Asia-Pacific, Europe, Latin America, and Middle East and Africa, where North America currently dominates the global market.
Some of the major players in the global neuroscience market include Alpha Omega Engineering, Biobserve GmbH, Blackrock Neurotech, Doric Lenses Inc., General Electric Company, Kernel, Laserglow Technologies, Mightex Systems, NeuroNexus Technologies Inc., Noldus Information Technology B.V., Plexon Inc., Prizmatix Ltd., and Siemens AG.
Swine Healthcare Market by Product (Diagnostic Tests, Therapeutics), Disease (Exudative Dermatitis, Coccidiosis, Respiratory Diseases, Swine Dysentery, Porcine Parvovirus, and Others), Route of Administration (Injectable, Oral), Distribution Channel (Veterinary Hospitals, Retail Pharmacy, Online Pharmacy), and Region 2023-2028
Epilepsy Drugs Market by Generation Type (First Generation Drugs, Second Generation Drugs, Third Generation Drugs), Anti-Epileptics Drugs Type (Narrow-Spectrum AEDs, Broad-Spectrum AEDs), Distribution Channel (Hospital Pharmacy, Pharmacy Stores, and Others), and Region 2023-2028
Congestive Heart Failure Drugs Market by Drug Class (ACE Inhibitors, Angiotensin 2 Receptor Blockers, Beta Blockers, Diuretics, Aldosterone Antagonists, Inotropes, and Others), Route of Administration (Oral, Intravenous), Distribution Channel (Hospital Pharmacies, Retail Pharmacies, Online Pharmacies), and Region 2023-2028
REACH OUT TO US
Call us on
( US: +1-631-791-1145 )
( UK: +44-753-713-2163 )
( India: +91 120 433 0800 )
Drop us an email at